Cover Image
市場調查報告書

手術用人工血管的全球市場:產品,原料,終端用戶,各地區的機會分析與產業預測

Vascular Graft Market by Product (Hemodialysis Access Graft, Endovascular Aneurysm Repair Stent Graft, and Peripheral Vascular Graft), by Raw Material, and by End-User - Global Opportunity Analysis and Industry Forecast, 2017-2023

出版商 Allied Market Research 商品編碼 539658
出版日期 內容資訊 英文 150 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
手術用人工血管的全球市場:產品,原料,終端用戶,各地區的機會分析與產業預測 Vascular Graft Market by Product (Hemodialysis Access Graft, Endovascular Aneurysm Repair Stent Graft, and Peripheral Vascular Graft), by Raw Material, and by End-User - Global Opportunity Analysis and Industry Forecast, 2017-2023
出版日期: 2017年08月01日 內容資訊: 英文 150 Pages
簡介

本報告提供手術用人工血管的全球市場調查,提供整體市場趨勢,各種類·原料·終端用戶·地區的詳細趨勢,市場規模的變化與預測,市場促進·阻礙因素以及市場機會分析,臨床實驗概要,主要企業簡介等系統性資訊。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 分析的要點
    • 主要的投資財源
    • 主要的成功策略
  • 主要企業的市場份額
  • 市場動態
    • 推動因素
    • 阻礙因素
    • 市場機會
    • 影響分析
  • 臨床實驗

第4章 手術用人工血管的全球市場:各類型

  • 市場概要
    • 市場規模與預測
  • 血液透析機用手術用人工血管
  • 動脈瘤修復支架用手術用人工血管
    • 主動脈瘤
    • 胸部主動脈瘤
  • 末梢手術用人工血管

第5章 手術用人工血管的全球市場:各原料

  • 市場概要
    • 市場規模與預測
  • 聚酯
  • 聚四氯乙烯(PTFE)
  • 聚氨酯
  • 生物合成材料

第6章 手術用人工血管的全球市場:各終端用戶

  • 市場概要
    • 市場規模與預測
  • 醫院
  • 門診外科中心

第7章 手術用人工血管的全球市場:各地區

  • 市場概要
  • 北美
    • 市場趨勢
    • 成長因素·市場機會
    • 市場規模·預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 市場趨勢
    • 成長因素·市場機會
    • 市場規模·預測
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 市場趨勢
    • 成長因素·市場機會
    • 市場規模·預測
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 其他
  • 南美·中東·非洲
    • 市場趨勢
    • 成長因素·市場機會
    • 市場規模·預測
    • 巴西
    • 南非
    • 沙烏地阿拉伯
    • 其他

第8章 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: LI 172435

A vascular graft is a medical device that acts as an artificial blood vessel. It is implanted in patients with blocked blood vessels to redirect the flow of blood from one organ to the other to restore the normal flow of blood within the body.

The global vascular graft market is driven by increase in the incidence of vascular disorders, high blood glucose level, hypertension, and other risk factors that cause blockage of blood vessels. The global vascular grafts market was valued at $4,192 million in 2016, and is expected to reach at $6,218 million by 2023, growing at a CAGR of 5.7% from 2017 to 2023. In addition, sedentary lifestyle, rise in geriatric population, and technological advancements supplement the market growth. However, high cost of treatment and increase in complications associated with prosthetic grafts restrain the market growth. Conversely, rise in awareness for vascular grafts and huge market opportunities in the emerging economies of Asia-Pacific and LAMEA regions are expected to provide numerous opportunities to the market players in the near future.

The global vascular graft market is segmented on the basis of product, raw material, end user, and region. On the basis of product, it is classified into endovascular stent graft, peripheral vascular graft, and hemodialysis access graft. The endovascular stent graft segment is bifurcated into abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). On the basis of raw material, it is categorized into polyester, polytetrafluoroethylene (PTFE), polyurethane, and biosynthetic. Based on end user, it is divided into hospitals & ambulatory surgical centers. The market is analyzed based on region into North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis of the market from 2016 to 2023 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Comprehensive analyses of the product type and raw materials help in understanding the regional trends and potential investment areas.
  • Key market players and their strategies have been thoroughly analyzed to understand the competitive outlook of the industry.

KEY MARKET SEGMENTS

By Product

  • Hemodialysis Access Graft
  • Endovascular Aneurysm Repair Stent Grafts
  • Abdominal Aortic Aneurysm (AAA)
  • Thoracic Aortic Aneurysm (TAA)
  • Peripheral Vascular Graft

By Raw Material

  • Polytetrafluoroethylene (PTFE)
  • Polyurethane (PU)
  • Polyester
  • Biosynthetic

By End User

  • Hospitals
  • Ambulatory Surgical Centers

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA
  • List of key players profiled in the report
  • B. Braun Melsungen AG
  • C. R. Bard Inc.
  • Cardinal Health Inc.
  • Cook Medical Inc.
  • Endologix Inc.
  • LeMaitre Vascular Inc.
  • MAQUET Holding B.V. & Co. KG (a Getinge Group Company)
  • Medtronic plc.
  • Terumo Corporation
  • W. L. Gore & Associates Inc.
  • List of the other players in the value chain (these players are not profiled in the report, the same can be included on request)
  • Cardiatis SA
  • JOTEC GmbH
  • Lombard Medical Inc.
  • Japan Lifeline Co. Ltd.
  • Nano Endoluminal

Table of Contents

CHAPTER 1 INTRODUCTION

  • 1.1. REPORT DESCRIPTION
  • 1.2. KEY BENEFITS FOR STAKEHOLDERS
  • 1.3. KEY MARKET SEGMENTS
  • 1.4. RESEARCH METHODOLOGY
    • 1.4.1. Secondary research
    • 1.4.2. Primary research
    • 1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

  • 2.1. KEY FINDINGS OF THE STUDY
  • 2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

  • 3.1. MARKET DEFINITION AND SCOPE
  • 3.2. KEY FINDINGS
    • 3.2.1. Top investment pockets
    • 3.2.2. Top winning strategies
      • 3.2.2.1. Competitive intelligence of companies and their strategies
  • 3.3. TOP PLAYER POSITIONING, 2016
  • 3.4. MARKET DYNAMICS
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in incidence of risk factors that lead to blockage of blood vessels
      • 3.4.1.2. Increase in geriatric population
      • 3.4.1.3. Technological advancements
      • 3.4.1.4. Lifestyle changes leading to blockage of blood vessels
    • 3.4.2. Restraints
      • 3.4.2.1. High cost of treatment
      • 3.4.2.2. Complications associated with prosthetic grafts
    • 3.4.3. Opportunities
      • 3.4.3.1. Growth opportunities in emerging markets
      • 3.4.3.2. Increase in awareness for vascular grafts
    • 3.4.4. Impact analysis
  • 3.5. CLINICAL TRIALS

CHAPTER 4 GLOBAL VASCULAR GRAFT MARKET, BY TYPE

  • 4.1. OVERVIEW
    • 4.1.1. Market size and forecast
  • 4.2. HEMODIALYSIS ACCESS GRAFT
    • 4.2.1. Key market trends
    • 4.2.2. Key growth factors and opportunities
    • 4.2.3. Market size and forecast
  • 4.3. ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS
    • 4.3.1. Abdominal Aortic Aneurysm (AAA)
    • 4.3.2. Thoracic Aortic Aneurysm (TAA)
    • 4.3.3. Key market trends
    • 4.3.4. Key growth factors and opportunities
    • 4.3.5. Market size and forecast
  • 4.4. PERIPHERAL VASCULAR GRAFT
    • 4.4.1. Key market trends
    • 4.4.2. Key growth factors and opportunities
    • 4.4.3. Market size and forecast

CHAPTER 5 VASCULAR GRAFT MARKET, BY RAW MATERIAL

  • 5.1. OVERVIEW
    • 5.1.1. Market size and forecast
  • 5.2. POLYESTER
    • 5.2.1. Market size and forecast
  • 5.3. POLYTETRAFLUOROETHYLENE (PTFE)
    • 5.3.1. Market size and forecast
  • 5.4. POLYURETHANE
    • 5.4.1. Market size and forecast
  • 5.5. BIOSYNTHETIC
    • 5.5.1. Market size and forecast

CHAPTER 6 VASCULAR GRAFT MARKET, BY END USER

  • 6.1. OVERVIEW
    • 6.1.1. Market size and forecast
  • 6.2. HOSPITALS
    • 6.2.1. Market size and forecast
  • 6.3. AMBULATORY SURGICAL CENTERS (ASCS)
    • 6.3.1. Market size and forecast

CHAPTER 7 VASCULAR GRAFT MARKET, BY REGION

  • 7.1. OVERVIEW
    • 7.1.1. Market size and forecast
  • 7.2. NORTH AMERICA
    • 7.2.1. Key market trends
    • 7.2.2. Key growth factors and opportunities
    • 7.2.3. Market size and forecast
    • 7.2.4. U.S.
    • 7.2.5. Canada
    • 7.2.6. Mexico
  • 7.3. EUROPE
    • 7.3.1. Key market trends
    • 7.3.2. Key growth factors and opportunities
    • 7.3.3. Market size and forecast
    • 7.3.4. Germany
    • 7.3.5. France
    • 7.3.6. UK
    • 7.3.7. Italy
    • 7.3.8. Spain
    • 7.3.9. Rest of Europe
  • 7.4. ASIA-PACIFIC
    • 7.4.1. Key market trends
    • 7.4.2. Key growth factors and opportunities
    • 7.4.3. Market size and forecast
    • 7.4.4. Japan
    • 7.4.5. China
    • 7.4.6. India
    • 7.4.7. South Korea
    • 7.4.8. Australia
    • 7.4.9. Rest of Asia-Pacific
  • 7.5. LAMEA
    • 7.5.1. Key market trends
    • 7.5.2. Key growth factors and opportunities
    • 7.5.3. Market size and forecast
    • 7.5.4. Brazil
    • 7.5.5. South Africa
    • 7.5.6. Saudi Arabia
    • 7.5.7. Rest of LAMEA

CHAPTER 8 COMPANY PROFILES

  • 8.1. B. BRAUN MELSUNGEN AG
    • 8.1.1. Company overview
    • 8.1.2. Company snapshot
    • 8.1.3. Operating business segments
    • 8.1.4. Product portfolio
    • 8.1.5. Business performance
    • 8.1.8. Key strategic moves and developments
  • 8.2. C. R. BARD, INC.
    • 8.2.1. Company overview
    • 8.2.2. Company snapshot
    • 8.2.3. Operating business segments
    • 8.2.4. Product portfolio
    • 8.2.5. Key strategic moves and developments
  • 8.3. CARDINAL HEALTH INC.
    • 8.3.1. Company overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Operating business segments
    • 8.3.4. Product portfolio
    • 8.3.5. Business performance
    • 8.3.8. Key strategic moves and developments
  • 8.4. COOK MEDICAL INC.
    • 8.4.1. Company overview
    • 8.4.2. Company snapshot
    • 8.4.3. Operating business segments
    • 8.4.4. Key strategic moves and developments
  • 8.5. ENDOLOGIX INC.
    • 8.5.1. Company overview
    • 8.5.2. Company snapshot
    • 8.5.3. Operating business segments
    • 8.5.4. Product portfolio
    • 8.5.5. Business performance
    • 8.5.8. Key strategic moves and developments
  • 8.6. LEMAITRE VASCULAR, INC.
    • 8.6.1. Company overview
    • 8.6.2. Company snapshot
    • 8.6.3. Operating business segments
    • 8.6.4. Product portfolio
    • 8.6.5. Business performance
    • 8.6.8. Key strategic moves and developments
  • 8.7. MAQUET HOLDING B.V. & CO. KG
    • 8.7.1. Company overview
    • 8.7.2. Company snapshot
    • 8.7.3. Operating business segments
    • 8.7.4. Product portfolio
    • 8.7.5. Key strategic moves and developments
  • 8.8. MEDTRONIC PLC
    • 8.8.1. Company overview
    • 8.8.2. Company snapshot
    • 8.8.3. Operating business segments
    • 8.8.4. Product portfolio
    • 8.8.5. Key strategic moves and developments
  • 8.9. TERUMO CORPORATION
    • 8.9.1. Company overview
    • 8.9.2. Company snapshot
    • 8.9.3. Operating product categories
    • 8.9.4. Product portfolio
    • 8.9.5. Business performance
    • 8.9.8. Key strategic moves and developments
  • 8.10. W. L. GORE & ASSOCIATES, INC.
    • 8.10.1. Company overview
    • 8.10.2. Company snapshot
    • 8.10.3. Operating business segments
    • 8.10.4. Product portfolio
Back to Top